PressAt
Monday 12 May, 2025
Cambridge, UK – May 12th, 2025 – Upfront Diagnostics, a pioneering medical technology company based in Cambridge, today announced it has raised $4.3 million in a funding round to accelerate the commercialization of its revolutionary stroke blood test, LVOne, in the UK and expand into new markets…
Read More
Upfront Diagnostics Secures $4.3 Million Funding to Commercialize Stroke Test
Upfront diagnostics
15:21
Monday 12 May, 2025 Cambridge, UK – May 12th, 2025 – Upfront Diagnostics, a pioneering medical technology company based in Cambridge, today announced it has raised $4.3 million in a funding round to accelerate the commercialization of its revolutionary stroke blood test, LVOne, in the UK and expand into new markets…
